@FiercePharma: Actavis CEO says generics biz "as we know it" is doomed as company launches branded pain drug in U.S. Release | Follow @FiercePharma
> Swiss drugmaker Acino plans to buy the Latin American and Asian businesses from Teva Pharmaceutical Industries' ($TEVA) generics unit Mepha, as part of a deal worth €94 million ($122 million). Report
> Analysts say Ranbaxy Laboratories' $500 million reserve for a settlement with the U.S. Justice Department will more than offset the gains from its exclusive launch of generic Lipitor. News
> Transcept Pharmaceuticals won a $10 million milestone payment from Purdue Pharma for the sleep drug Intermezzo's new listing in the FDA Orange Book. Story
> Dental anesthetic maker Novocol Pharmaceutical is spending about $54 million to upgrade a plant in Ontario, Canada. Release
> Indian officials suggest that the country follow the U.S. and EU in sharing manufacturing inspections, in this case with neighboring countries in Asia and Africa. News
> Miami-based Opko Health is buying the Israeli active pharmaceutical ingredients manufacturer FineTech Pharmaceutical; terms weren't disclosed. Article
Biotech News
@FierceBiotech: More than 1/3 of clinical trials conducted by pharma cos. are now being outsourced, says a Kalorama report. Story | Follow @FierceBiotech
@JohnCFierce: Proposed "model" plan would restrict portions of sensitive studies to "legitimate scientists." Via WSJ: News | Follow@JohnCFierce
@RyanMFierce: Seattle's #biotech scene lacked startup activity in '11 but didn't want for M&A action via @ldtimmerman. Article | Follow @RyanMFierce
> Roche CEO Schwan outlines drug/diagnostic acquisition strategy. News
> Vivus sinks after delivering oral cleft data on obesity drug ingredient. More
Vaccines News
> Pfizer, GSK to provide more discount vaccines for GAVI. Story
> Oxford researchers find malaria vaccine target. Article
Manufacturing News
> FDA cites Akzo for contamination, leaky equipment. News
> Counterfeiter with Chinese connections is busted. Story
> Daiichi grimaces at Ranbaxy, FDA consent decree. Report
> Trout forges ahead on Novartis-MIT continuous processing effort. Article
And Finally... Mutations in a single gene are associated with rare ovarian, uterine and testicular cancers that previously appeared unrelated, researchers found. Report